The strong HDAC inhibitor LBH589 clearly was more efficient than pirfenidone in inactivating IPF-fibroblasts, through induction of cell cycle arrest and apoptosis, an effect pirfenidone did not exert. This evidence concerns the gene HDAC9 and idiopathic pulmonary fibrosis.